Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Amantadine 100mg capsules
0409010B0AAAAAA
|
Amantadine hydrochloride (Parkinsonism) | Amantadine hydrochloride | Central Nervous System | 35,631 |
|
Amantadine 50mg/5ml oral solution sugar free
0409010B0AAABAB
|
Amantadine hydrochloride (Parkinsonism) | Amantadine hydrochloride | Central Nervous System | 919 |
|
Trilasym 50mg/5ml oral solution
0409010B0BCAAAB
|
Trilasym | Amantadine hydrochloride | Central Nervous System | 5 |
|
Amantadine 100mg tablets
0503040C0AAABAB
|
Amantadine hydrochloride (Antiviral) | Amantadine hydrochloride | Infections | No data available |
|
Lysovir 100mg capsules
0503040C0BBAAAA
|
Lysovir | Amantadine hydrochloride | Infections | No data available |
|
Symmetrel 100mg capsules
0409010B0BBAAAA
|
Symmetrel | Amantadine hydrochloride | Central Nervous System | No data available |
|
Symmetrel 50mg/5ml syrup
0409010B0BBABAB
|
Symmetrel | Amantadine hydrochloride | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.